Keyword: Japan

Chugai Pharmaceuticals is shelling out ¥127.3 billion on a new R&D site in Yokohama, where it will combine the work of two research labs in nearby cities.

The week’s biotech discoveries included compounds in broccoli and ragweed with potential disease-fighting properties.

A cocktail of drugs known as adrenergic receptor antagonists normalized brain potassium levels and restored movement in mice.

The pair has been studying imeglimin, a new type of drug the partners say is the first clinical candidate in a new chemical class of oral agents.

Novo Nordisk has partnered with Taiwan-based Health2Sync to help promote the latter’s digital diabetes management app in Japan.

Akili Interactive is teaming up with Osaka-based Shionogi to help bring the first prescription digital therapeutics to Japan and Taiwan.

Japanese pharma Daiichi Sankyo is looking to boost its research focus with a series of changes across its R&D.

The week’s biotech news included insight into how circulating tumor cells form metastases and how bacteria evade copper antibiotics.

Amgen heads into an FDA adcomm for new osteoporosis drug Evenity next week comforted by a first approval for the bone-building drug in Japan.